Unlock 30% off global market reports with code ONLINE30 – get insights on tariff changes, macro trends, and global economic shifts.
What is the current market size of the diabetes pen industry, and what growth rate is it expected to achieve?
The diabetes pen market size has grown strongly in recent years. It will grow from $29.24 billion in 2024 to $31.22 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to managing scarce water resources, ageing water infrastructure, escalating call for quality water services, rising demand for smart water solutions, improving efficiency in operation.
The diabetes pen market size is expected to see strong growth in the next few years. It will grow to $40.17 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to growing population and urbanization, increasing water pollution and contamination, need for efficient resource management, need for accurate and real-time water data, increasing demand for water reuse and recycling. Major trends in the forecast period include advancements in digital technologies such as ai and ml, increasing adoption of iot and cloud computing, pressing need to address water-related challenges, increasing investment in water infrastructure, escalating digitization of the utility sector.
Download Your Free Sample PDF:
What are the major drivers contributing to the growth of the diabetes pen market?
The increasing prevalence of diabetes worldwide is expected to propel the growth of the diabetes pen market going forward. Diabetes refers to a group of chronic metabolic diseases characterized by elevated blood sugar levels (hyperglycemia). Diabetes pens are a type of insulin delivery device that allows for more accurate dosing, better adherence, and less hypoglycemia risk. The pens are also associated with less injection site pain and are preferred by people with diabetes requiring insulin For instance, in May 2023, according to the American Diabetes Association, a US-based professional organization, in 2021, the age-adjusted prevalence of Impaired glucose tolerance (IGT) among adults aged 20–79 years worldwide was 9.1% (464 million), by 2045, this figure is projected to increase to 10.0% (638 million). Therefore, the increasing prevalence of diabetes worldwide is driving the growth of the diabetes pen market.
What are the major market segments driving the growth of the diabetes pen industry?
The diabetes pen market covered in this report is segmented –
1) By Product: Insulin Pens, Pen Needles
2) By Usage: Reusable Injection Pens, Disposable Injection Pens
3) By Therapy: Insulin, Glucagon-like Peptide-1, Growth Hormones, Fertility, Osteoporosis
4) By Distribution Channel: Retail Pharmacies, Online Medical Stores, Diabetes Clinics
Subsegments:
1) By Insulin Pens: Pre-Filled Insulin Pens, Disposable Insulin Pens, Reusable Insulin Pens
2) By Pen Needles: Standard Pen Needles, Safety Pen Needles, Specialty Pen Needles
View The Full Market Report:
What are the most notable trends influencing investment in the diabetes pen sector?
Major companies operating in the diabetes pen market are focused on developing innovative products, such as virtually painless injections, to enhance the user experience. A virtually painless injection refers to an injection method designed to minimize discomfort during the administration of medication. It is designed to enhance patient comfort, making it easier for individuals to manage their insulin administration without fear or discomfort. For instance, in May 2022, Roche AG, a Switzerland-based medical equipment company, launched ACCU-FINE pen needles. It is designed to enhance the insulin delivery experience for users. These needles aim to provide a virtually painless injection while improving compliance and health outcomes for individuals with diabetes.
Who are the key market players contributing to the growth of the diabetes pen industry?
Major companies operating in the diabetes pen market report are F. Hoffman La Roche AG, Sanofi S.A., Astra Zeneca PLC, Fujitsu Limited, Eli Lilly and Company, Bayer Cropscience Ltd., Ericsson, Novo Nordisk A/S, BD, Bristol-Myers Squibb, Teruma Medical Corporation, Smiths Group plc., Greinier Bio One International GmBH (U.S.), YPSOMED, Owen Mumford Ltd., WOCKHARDT, Nipro Europe Group Companies, Biocon, Copernicus, Mannkind Corporation, Jiangsu Delfu medical device Co., HTL-STREFA Inc., DeepSig, Injex UK Ltd.
Which regions are leading the growth of the diabetes pen market globally?
North America was the largest region in the diabetes pen market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetes pen market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can Companies Use The Diabetes Pen Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.
Purchase The Report And Get A Swift Delivery:
Need Customized Data On Diabetes Pen Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you're entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
Request Customized Data:
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment